Equity · Healthcare
BRKR
NASDAQBruker (BRKR)
The line runs 57.01 USD on 11 August through 61.31 USD on 6 November, on a scale from 50 to 70. Days the market did not trade hold the previous close, flat.
- Market cap
- 9.3B USD
- Revenue, year to Dec 2025
- 3.4B USD
- EPS, diluted, year to Dec 2025
- −0.15 USD
- 52-week range
- 32.76 USD – 65 USD
- Avg volume
- 183.1K
as of Nov 6, 2026
Which funds hold Bruker (BRKR)?
8 of the 45 institutional funds we track reported a Bruker position for the quarter ended 30 Jun 2026 — a combined 252.6M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Added | 2,512,706 | 149.5M USD | +94.3% |
| Viking Global Investors | New position | 893,491 | 53.8M USD | |
| Glenview Capital Management | New position | 252,169 | 15.2M USD | |
| Citadel Advisors | Held (±25%) | 178,195 | 10.7M USD | −9.0% |
| D. E. Shaw & Co. | Added | 135,853 | 8.2M USD | +195.8% |
| Two Sigma Investments | Trimmed | 112,660 | 6.8M USD | −81.7% |
| Marshall Wace | Held (±25%) | 99,032 | 6.0M USD | +15.9% |
| Bridgewater Associates | New position | 42,339 | 2.5M USD | |
| Balyasny Asset Management | Exited | |||
| Millennium Management | Exited |
What has been filed or recorded for Bruker (BRKR)?
The filings we hold for Bruker, newest first: 2 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 02 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 02 Oct 2026 | Fails to deliver | Shares failed to deliver | 14 shares | 867 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Fails to deliver | Shares failed to deliver | 39,882 shares | 2.6M USD notional · 0.026% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.81 USD | |
| 30 Sep 2026 | Financials | Total assets | 5.8B USD | at period end |
| 30 Sep 2026 | Financials | Total equity incl. minority interest | 2.3B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.41 USD | |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.02 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −0.15 USD | |
| 31 Dec 2025 | Financials | Revenue | 3.4B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −8.6M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −0.15 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.41 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.05 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.11 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 0.76 USD |
Bruker (BRKR): frequently asked questions
What did Bruker shares close at?
Bruker closed at 61.31 USD on 6 Nov 2026, up 5.69% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Bruker’s market cap?
Bruker is worth 9.3B USD by market value as of 6 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Bruker’s revenue?
Bruker reported revenue of 3.4B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Which funds own Bruker?
8 of the 45 funds we track reported a Bruker position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Viking Global Investors and Glenview Capital Management. See Funds
When did Bruker last report earnings?
Bruker last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.81 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings